

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.32159265 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.32159265 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.02616843 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.67180739 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.28656328 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 5.01713044 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 5.01713044 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.66961338 |
| 9 | hemidesmosome assembly (GO:0031581) | 4.41931259 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.36494255 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28475750 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.28475750 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.22115256 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.94718729 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.88856057 |
| 16 | cell-substrate junction assembly (GO:0007044) | 3.75249366 |
| 17 | negative T cell selection (GO:0043383) | 3.74344533 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.74110284 |
| 19 | T cell migration (GO:0072678) | 3.70351970 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 3.68752093 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.63418220 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.63418220 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.63418220 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.63418220 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.63418220 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.63418220 |
| 27 | negative regulation of phagocytosis (GO:0050765) | 3.62259103 |
| 28 | interferon-gamma production (GO:0032609) | 3.62071261 |
| 29 | protein localization to endosome (GO:0036010) | 3.57897836 |
| 30 | response to interleukin-15 (GO:0070672) | 3.55692789 |
| 31 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.51993528 |
| 32 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.50417460 |
| 33 | leukocyte aggregation (GO:0070486) | 3.49855283 |
| 34 | thymic T cell selection (GO:0045061) | 3.48671780 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.44875906 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 3.43259150 |
| 37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.41371641 |
| 38 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.39551530 |
| 39 | tolerance induction (GO:0002507) | 3.38025264 |
| 40 | mannose metabolic process (GO:0006013) | 3.37130853 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36186341 |
| 42 | positive regulation of histone deacetylation (GO:0031065) | 3.29018238 |
| 43 | positive T cell selection (GO:0043368) | 3.27997717 |
| 44 | barbed-end actin filament capping (GO:0051016) | 3.16142696 |
| 45 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.15496037 |
| 46 | T cell selection (GO:0045058) | 3.12959964 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.12796105 |
| 48 | leukocyte cell-cell adhesion (GO:0007159) | 3.11312570 |
| 49 | focal adhesion assembly (GO:0048041) | 3.09470972 |
| 50 | cell-substrate adherens junction assembly (GO:0007045) | 3.09470972 |
| 51 | regulation of histone H3-K27 methylation (GO:0061085) | 3.06394594 |
| 52 | DNA unwinding involved in DNA replication (GO:0006268) | 3.06106651 |
| 53 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.05709799 |
| 54 | cellular extravasation (GO:0045123) | 3.03979999 |
| 55 | pentose-phosphate shunt (GO:0006098) | 3.02419724 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00887258 |
| 57 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.98634392 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 2.98195149 |
| 59 | nuclear pore complex assembly (GO:0051292) | 2.97625218 |
| 60 | protein retention in ER lumen (GO:0006621) | 2.97088935 |
| 61 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96767655 |
| 62 | positive regulation of isotype switching (GO:0045830) | 2.94720780 |
| 63 | positive regulation of interferon-alpha production (GO:0032727) | 2.93239782 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92490302 |
| 65 | adherens junction assembly (GO:0034333) | 2.91907993 |
| 66 | hypotonic response (GO:0006971) | 2.91559563 |
| 67 | natural killer cell differentiation (GO:0001779) | 2.91231252 |
| 68 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.87784165 |
| 69 | negative regulation of interleukin-12 production (GO:0032695) | 2.87158038 |
| 70 | response to type I interferon (GO:0034340) | 2.85293832 |
| 71 | regulation of response to interferon-gamma (GO:0060330) | 2.85215868 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 2.82249407 |
| 73 | respiratory burst (GO:0045730) | 2.81708149 |
| 74 | cellular response to interleukin-15 (GO:0071350) | 2.81225366 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.78031201 |
| 76 | type I interferon signaling pathway (GO:0060337) | 2.78031201 |
| 77 | embryonic process involved in female pregnancy (GO:0060136) | 2.77977053 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77636994 |
| 79 | pinocytosis (GO:0006907) | 2.77101502 |
| 80 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.76147620 |
| 81 | proline biosynthetic process (GO:0006561) | 2.75318107 |
| 82 | T cell costimulation (GO:0031295) | 2.75268093 |
| 83 | negative regulation of granulocyte differentiation (GO:0030853) | 2.73357717 |
| 84 | stress fiber assembly (GO:0043149) | 2.72892181 |
| 85 | skin morphogenesis (GO:0043589) | 2.71540688 |
| 86 | cell adhesion mediated by integrin (GO:0033627) | 2.71508362 |
| 87 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.71427800 |
| 88 | response to muramyl dipeptide (GO:0032495) | 2.70461351 |
| 89 | basement membrane organization (GO:0071711) | 2.69442876 |
| 90 | lymphocyte costimulation (GO:0031294) | 2.69186426 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.68545819 |
| 92 | regulation of translational fidelity (GO:0006450) | 2.68177426 |
| 93 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.67571626 |
| 94 | positive regulation of protein deacetylation (GO:0090312) | 2.67348904 |
| 95 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.64979782 |
| 96 | hyaluronan catabolic process (GO:0030214) | 2.64689962 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.63547188 |
| 98 | negative regulation of cell size (GO:0045792) | 2.62327681 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.62053619 |
| 100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.62053619 |
| 101 | protein maturation by protein folding (GO:0022417) | 2.61834058 |
| 102 | natural killer cell activation (GO:0030101) | 2.61799108 |
| 103 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61684653 |
| 104 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.61191441 |
| 105 | macrophage activation involved in immune response (GO:0002281) | 2.60956659 |
| 106 | T cell proliferation (GO:0042098) | 2.60208097 |
| 107 | regulation of extracellular matrix disassembly (GO:0010715) | 2.60196975 |
| 108 | T cell homeostasis (GO:0043029) | 2.59528587 |
| 109 | heterotypic cell-cell adhesion (GO:0034113) | 2.58727173 |
| 110 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.58720513 |
| 111 | myeloid dendritic cell activation (GO:0001773) | 2.58700330 |
| 112 | response to laminar fluid shear stress (GO:0034616) | 2.58570794 |
| 113 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.58435870 |
| 114 | positive regulation of antigen processing and presentation (GO:0002579) | 2.58096288 |
| 115 | positive regulation of macrophage differentiation (GO:0045651) | 2.55583997 |
| 116 | response to protozoan (GO:0001562) | 2.54767195 |
| 117 | T cell receptor signaling pathway (GO:0050852) | 2.54316150 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.54233418 |
| 119 | neutrophil activation (GO:0042119) | 2.54180370 |
| 120 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.54175072 |
| 121 | actin nucleation (GO:0045010) | 2.54120281 |
| 122 | positive regulation of lamellipodium assembly (GO:0010592) | 2.53702184 |
| 123 | positive regulation of interleukin-2 production (GO:0032743) | 2.53277071 |
| 124 | low-density lipoprotein particle clearance (GO:0034383) | 2.52927837 |
| 125 | regulation of defense response to virus by virus (GO:0050690) | 2.52794768 |
| 126 | myeloid cell activation involved in immune response (GO:0002275) | 2.51698002 |
| 127 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.49896936 |
| 128 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.49765157 |
| 129 | positive regulation of B cell mediated immunity (GO:0002714) | 2.49765157 |
| 130 | NADPH regeneration (GO:0006740) | 2.49763687 |
| 131 | glucose catabolic process (GO:0006007) | 2.49178872 |
| 132 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.48802815 |
| 133 | membrane raft organization (GO:0031579) | 2.48226382 |
| 134 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.48150581 |
| 135 | vesicle coating (GO:0006901) | 2.47100174 |
| 136 | lymphocyte homeostasis (GO:0002260) | 2.46952324 |
| 137 | cortical actin cytoskeleton organization (GO:0030866) | 2.46821052 |
| 138 | apoptotic process involved in morphogenesis (GO:0060561) | 2.46129081 |
| 139 | mast cell activation (GO:0045576) | 2.45989631 |
| 140 | regulation of early endosome to late endosome transport (GO:2000641) | 2.43752677 |
| 141 | membrane protein ectodomain proteolysis (GO:0006509) | 2.42520450 |
| 142 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.41328843 |
| 143 | positive regulation of nuclease activity (GO:0032075) | 2.41128551 |
| 144 | platelet aggregation (GO:0070527) | 2.39139532 |
| 145 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.36808874 |
| 146 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.34277196 |
| 147 | endodermal cell differentiation (GO:0035987) | 2.34233158 |
| 148 | cellular response to interleukin-4 (GO:0071353) | 2.33985925 |
| 149 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.33806464 |
| 150 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.33577962 |
| 151 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.31766293 |
| 152 | mammary gland epithelial cell proliferation (GO:0033598) | 2.30610413 |
| 153 | peptidyl-proline hydroxylation (GO:0019511) | 2.29585054 |
| 154 | activation of Rac GTPase activity (GO:0032863) | 2.29410810 |
| 155 | negative regulation of stress fiber assembly (GO:0051497) | 2.28992043 |
| 156 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.28649651 |
| 157 | negative regulation of viral release from host cell (GO:1902187) | 2.27041729 |
| 158 | modulation by symbiont of host cellular process (GO:0044068) | 2.26945184 |
| 159 | tricarboxylic acid metabolic process (GO:0072350) | 2.26881568 |
| 160 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.24999583 |
| 161 | definitive hemopoiesis (GO:0060216) | 2.24558869 |
| 162 | nuclear pore organization (GO:0006999) | 2.24345833 |
| 163 | ER-nucleus signaling pathway (GO:0006984) | 2.23552460 |
| 164 | negative regulation of fatty acid transport (GO:2000192) | 2.19261592 |
| 165 | protein hydroxylation (GO:0018126) | 2.18886510 |
| 166 | regulation of nuclease activity (GO:0032069) | 2.18801183 |
| 167 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.18514328 |
| 168 | mitotic chromosome condensation (GO:0007076) | 2.17235765 |
| 169 | cellular response to unfolded protein (GO:0034620) | 2.17146560 |
| 170 | maternal placenta development (GO:0001893) | 2.16801134 |
| 171 | glucose 6-phosphate metabolic process (GO:0051156) | 2.16744096 |
| 172 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.16205673 |
| 173 | COPII vesicle coating (GO:0048208) | 2.16081334 |
| 174 | protein export from nucleus (GO:0006611) | 2.16003907 |
| 175 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.15037205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21982885 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.89384874 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.86753480 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46990179 |
| 5 | * E2F7_22180533_ChIP-Seq_HELA_Human | 3.37746862 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.27062583 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.23952715 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.13754472 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12680439 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.88594176 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.81098387 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.79464511 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66390420 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62792271 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57138133 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50410420 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48116258 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47255189 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.39046260 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38903910 |
| 21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.36857072 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23951127 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23710834 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.18394700 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.12944023 |
| 26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12866946 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12007423 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 2.09066264 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.06172584 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05839796 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03921784 |
| 32 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03561846 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98362097 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98348851 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98128144 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97766895 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94587413 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.92193285 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92167874 |
| 40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83710370 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78614651 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77967391 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.75272432 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73847722 |
| 45 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72167872 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64665048 |
| 47 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59291722 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.55271465 |
| 49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.54748482 |
| 50 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.53335853 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.49255675 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48259093 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45867809 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45670446 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44656884 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43715097 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42579676 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40737751 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39846835 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36303391 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33717830 |
| 62 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31232472 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31029732 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30661413 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28254025 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28136792 |
| 67 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25139547 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25098012 |
| 69 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23708267 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23599877 |
| 71 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22862767 |
| 72 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22770724 |
| 73 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20060287 |
| 74 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18632655 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18481508 |
| 76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17366942 |
| 77 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.16884354 |
| 78 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16267153 |
| 79 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16184613 |
| 80 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16053214 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15756582 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15606196 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15421929 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14538577 |
| 85 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14030759 |
| 86 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.11894418 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11825851 |
| 88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10489561 |
| 89 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10349003 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09578664 |
| 91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09552864 |
| 92 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.08845915 |
| 93 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.08228610 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07971250 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06931624 |
| 96 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06725986 |
| 97 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.05749390 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05332884 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04563688 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04563688 |
| 101 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04103714 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01941528 |
| 103 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01875599 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01497009 |
| 105 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99582413 |
| 106 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99376379 |
| 107 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97719481 |
| 108 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97621921 |
| 109 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97558133 |
| 110 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95751210 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94850677 |
| 112 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94332735 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93657046 |
| 114 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93429372 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92095230 |
| 116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92056614 |
| 117 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91687779 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89585686 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88653613 |
| 120 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88108341 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87715863 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87188478 |
| 123 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86874606 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85183212 |
| 125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84807106 |
| 126 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84769218 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84193485 |
| 128 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83893785 |
| 129 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83866108 |
| 130 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.83476477 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81863676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.35222934 |
| 2 | MP0003436_decreased_susceptibility_to | 2.87651849 |
| 3 | MP0003303_peritoneal_inflammation | 2.84937711 |
| 4 | MP0000685_abnormal_immune_system | 2.79655091 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.78594507 |
| 6 | MP0001800_abnormal_humoral_immune | 2.64964872 |
| 7 | MP0005387_immune_system_phenotype | 2.64685323 |
| 8 | MP0001790_abnormal_immune_system | 2.64685323 |
| 9 | MP0005671_abnormal_response_to | 2.63160897 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.54099728 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.46022445 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.39993259 |
| 13 | MP0005451_abnormal_body_composition | 2.37908168 |
| 14 | MP0002723_abnormal_immune_serum | 2.27100977 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.26330460 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.26251937 |
| 17 | MP0001819_abnormal_immune_cell | 2.23935183 |
| 18 | MP0009785_altered_susceptibility_to | 2.21108470 |
| 19 | MP0005025_abnormal_response_to | 2.20340694 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.16998311 |
| 21 | MP0006082_CNS_inflammation | 2.16647198 |
| 22 | MP0002419_abnormal_innate_immunity | 2.16622015 |
| 23 | MP0004272_abnormal_basement_membrane | 2.16006148 |
| 24 | MP0002398_abnormal_bone_marrow | 2.09677262 |
| 25 | MP0008260_abnormal_autophagy | 2.08699679 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.98431643 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.97356772 |
| 28 | MP0002405_respiratory_system_inflammati | 1.95763438 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.90265400 |
| 30 | MP0002006_tumorigenesis | 1.89323882 |
| 31 | MP0000716_abnormal_immune_system | 1.87962290 |
| 32 | MP0003724_increased_susceptibility_to | 1.86723864 |
| 33 | MP0001849_ear_inflammation | 1.86206422 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.84503097 |
| 35 | MP0004947_skin_inflammation | 1.78382456 |
| 36 | MP0009278_abnormal_bone_marrow | 1.78004113 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.76740119 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.76439051 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.75430059 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.75296546 |
| 41 | MP0002722_abnormal_immune_system | 1.72404933 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.71529744 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.69239372 |
| 44 | MP0010307_abnormal_tumor_latency | 1.66081857 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.62704985 |
| 46 | MP0003448_altered_tumor_morphology | 1.61196211 |
| 47 | MP0002429_abnormal_blood_cell | 1.60250896 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.59625793 |
| 49 | MP0000858_altered_metastatic_potential | 1.59339019 |
| 50 | MP0002060_abnormal_skin_morphology | 1.59289206 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.57786044 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.57786044 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.57453367 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.54830683 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.53148606 |
| 56 | MP0001873_stomach_inflammation | 1.48017233 |
| 57 | MP0004510_myositis | 1.46545704 |
| 58 | MP0004233_abnormal_muscle_weight | 1.44680864 |
| 59 | MP0002933_joint_inflammation | 1.43394702 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.42586321 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.38607099 |
| 62 | MP0002796_impaired_skin_barrier | 1.37335918 |
| 63 | MP0001853_heart_inflammation | 1.34770672 |
| 64 | MP0003866_abnormal_defecation | 1.32345806 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.31483270 |
| 66 | MP0005409_darkened_coat_color | 1.29714639 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.27176846 |
| 68 | MP0001661_extended_life_span | 1.24840161 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.24232783 |
| 70 | MP0000490_abnormal_crypts_of | 1.24068355 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.20942331 |
| 72 | MP0005310_abnormal_salivary_gland | 1.17145224 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.15643060 |
| 74 | MP0005023_abnormal_wound_healing | 1.14551023 |
| 75 | MP0005670_abnormal_white_adipose | 1.14087379 |
| 76 | MP0008469_abnormal_protein_level | 1.13426021 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.09841623 |
| 78 | MP0003828_pulmonary_edema | 1.07591030 |
| 79 | MP0005501_abnormal_skin_physiology | 1.07296089 |
| 80 | MP0005621_abnormal_cell_physiology | 1.06371957 |
| 81 | MP0003091_abnormal_cell_migration | 1.06041206 |
| 82 | MP0001216_abnormal_epidermal_layer | 1.04831485 |
| 83 | MP0001348_abnormal_lacrimal_gland | 1.04826890 |
| 84 | MP0000343_altered_response_to | 1.04086290 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 1.03225368 |
| 86 | MP0000569_abnormal_digit_pigmentation | 1.02908150 |
| 87 | MP0006054_spinal_hemorrhage | 1.00297319 |
| 88 | MP0003279_aneurysm | 1.00044189 |
| 89 | MP0009840_abnormal_foam_cell | 0.99563215 |
| 90 | MP0003045_fibrosis | 0.98774937 |
| 91 | MP0001730_embryonic_growth_arrest | 0.96917148 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.95118999 |
| 93 | MP0004381_abnormal_hair_follicle | 0.94420815 |
| 94 | MP0001851_eye_inflammation | 0.94274591 |
| 95 | MP0004858_abnormal_nervous_system | 0.93372302 |
| 96 | MP0009931_abnormal_skin_appearance | 0.93213048 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.93127693 |
| 98 | MP0001958_emphysema | 0.92994943 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.89810523 |
| 100 | MP0003111_abnormal_nucleus_morphology | 0.89510814 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.88858803 |
| 102 | MP0004130_abnormal_muscle_cell | 0.87520461 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.86653338 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 0.86057019 |
| 105 | MP0000678_abnormal_parathyroid_gland | 0.86011131 |
| 106 | MP0002009_preneoplasia | 0.85980981 |
| 107 | MP0000350_abnormal_cell_proliferation | 0.84103257 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.83549044 |
| 109 | MP0000733_abnormal_muscle_development | 0.81084368 |
| 110 | MP0001243_abnormal_dermal_layer | 0.80388278 |
| 111 | MP0009115_abnormal_fat_cell | 0.80214782 |
| 112 | MP0005390_skeleton_phenotype | 0.78426242 |
| 113 | MP0008961_abnormal_basal_metabolism | 0.77872701 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.77419169 |
| 115 | MP0002080_prenatal_lethality | 0.74996331 |
| 116 | MP0000249_abnormal_blood_vessel | 0.74866147 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.74767547 |
| 118 | MP0009384_cardiac_valve_regurgitation | 0.74676910 |
| 119 | MP0001881_abnormal_mammary_gland | 0.74529937 |
| 120 | MP0003959_abnormal_lean_body | 0.74050063 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.73752634 |
| 122 | MP0003795_abnormal_bone_structure | 0.72402404 |
| 123 | MP0009763_increased_sensitivity_to | 0.71752325 |
| 124 | MP0002970_abnormal_white_adipose | 0.68348466 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.62413279 |
| 126 | MP0000371_diluted_coat_color | 0.62403925 |
| 127 | MP0000609_abnormal_liver_physiology | 0.61362157 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.60994405 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.60093115 |
| 130 | MP0005275_abnormal_skin_tensile | 0.59923376 |
| 131 | MP0000604_amyloidosis | 0.59642080 |
| 132 | MP0001915_intracranial_hemorrhage | 0.58684468 |
| 133 | MP0005166_decreased_susceptibility_to | 0.58417876 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.57846988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.37925280 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.20785176 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.96991126 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.78026192 |
| 5 | Recurrent viral infections (HP:0004429) | 3.64437641 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.61727312 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54795973 |
| 8 | Myositis (HP:0100614) | 3.53558390 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.50135309 |
| 10 | Chronic otitis media (HP:0000389) | 3.48206047 |
| 11 | Cellulitis (HP:0100658) | 3.47817200 |
| 12 | T lymphocytopenia (HP:0005403) | 3.46631006 |
| 13 | Recurrent bronchitis (HP:0002837) | 3.46336394 |
| 14 | Nasal polyposis (HP:0100582) | 3.30947126 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.27889389 |
| 16 | IgM deficiency (HP:0002850) | 3.26565498 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.14490172 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.09576394 |
| 19 | Abnormality of the nasal mucosa (HP:0000433) | 3.07052911 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.00768728 |
| 21 | Abnormality of T cells (HP:0002843) | 2.92107618 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.89553175 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.88252663 |
| 24 | Spontaneous hematomas (HP:0007420) | 2.88153540 |
| 25 | Inflammation of the large intestine (HP:0002037) | 2.88070401 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 2.86985505 |
| 27 | Atrophic scars (HP:0001075) | 2.83478423 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.83285411 |
| 29 | Meningitis (HP:0001287) | 2.79508128 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 2.79322962 |
| 31 | Increased density of long bones (HP:0006392) | 2.76949087 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74701709 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74701709 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72038023 |
| 35 | Orchitis (HP:0100796) | 2.70064854 |
| 36 | Pustule (HP:0200039) | 2.69970414 |
| 37 | Abnormality of oral frenula (HP:0000190) | 2.68986068 |
| 38 | Increased connective tissue (HP:0009025) | 2.67314412 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.65831015 |
| 40 | Broad face (HP:0000283) | 2.65561820 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.63307854 |
| 42 | Vasculitis (HP:0002633) | 2.61390167 |
| 43 | Recurrent skin infections (HP:0001581) | 2.61044151 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.60742057 |
| 45 | Colitis (HP:0002583) | 2.60405966 |
| 46 | Papilloma (HP:0012740) | 2.53776383 |
| 47 | Verrucae (HP:0200043) | 2.53776383 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.53004693 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.52160488 |
| 50 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.49747539 |
| 51 | Abnormality of the fingertips (HP:0001211) | 2.48200626 |
| 52 | Thrombocytosis (HP:0001894) | 2.48180197 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.47369681 |
| 54 | Fragile skin (HP:0001030) | 2.46475387 |
| 55 | Hyperacusis (HP:0010780) | 2.44464657 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.43645313 |
| 57 | Ankyloglossia (HP:0010296) | 2.43463546 |
| 58 | Hematochezia (HP:0002573) | 2.42225329 |
| 59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.41923449 |
| 60 | Obstructive lung disease (HP:0006536) | 2.41849174 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41849174 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.41361730 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.40903945 |
| 64 | Osteomyelitis (HP:0002754) | 2.40790993 |
| 65 | Increased IgE level (HP:0003212) | 2.39870052 |
| 66 | Spinal rigidity (HP:0003306) | 2.39066680 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.37573367 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37573367 |
| 69 | Arterial thrombosis (HP:0004420) | 2.37006617 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.36673096 |
| 71 | Optic neuritis (HP:0100653) | 2.36673096 |
| 72 | Aortic aneurysm (HP:0004942) | 2.36590184 |
| 73 | Abnormal platelet volume (HP:0011876) | 2.36189217 |
| 74 | Periodontitis (HP:0000704) | 2.35468099 |
| 75 | Gingivitis (HP:0000230) | 2.33416893 |
| 76 | Emphysema (HP:0002097) | 2.33138304 |
| 77 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29812743 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 2.29812743 |
| 79 | Short nail (HP:0001799) | 2.27552162 |
| 80 | Lymphopenia (HP:0001888) | 2.24972850 |
| 81 | Myocardial infarction (HP:0001658) | 2.22236624 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21255425 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21255425 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21255425 |
| 85 | Wormian bones (HP:0002645) | 2.20851079 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19497842 |
| 87 | Stomatitis (HP:0010280) | 2.18812353 |
| 88 | Disproportionate tall stature (HP:0001519) | 2.18756991 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16526512 |
| 90 | Spinal cord lesions (HP:0100561) | 2.15433108 |
| 91 | Syringomyelia (HP:0003396) | 2.15433108 |
| 92 | Ankle contracture (HP:0006466) | 2.13767188 |
| 93 | Petechiae (HP:0000967) | 2.12434356 |
| 94 | Leukocytosis (HP:0001974) | 2.12202084 |
| 95 | Pulmonary infiltrates (HP:0002113) | 2.11539423 |
| 96 | Milia (HP:0001056) | 2.09708154 |
| 97 | Hemoptysis (HP:0002105) | 2.07487952 |
| 98 | Epistaxis (HP:0000421) | 2.06730791 |
| 99 | Impaired platelet aggregation (HP:0003540) | 2.06344446 |
| 100 | Abnormal platelet function (HP:0011869) | 2.06344446 |
| 101 | Back pain (HP:0003418) | 2.04489130 |
| 102 | Biconcave vertebral bodies (HP:0004586) | 2.04075335 |
| 103 | Achilles tendon contracture (HP:0001771) | 2.03952703 |
| 104 | Gastrointestinal stroma tumor (HP:0100723) | 2.01865996 |
| 105 | Onycholysis (HP:0001806) | 2.01482946 |
| 106 | Distal lower limb muscle weakness (HP:0009053) | 2.01246093 |
| 107 | IgA deficiency (HP:0002720) | 2.00937358 |
| 108 | Frequent falls (HP:0002359) | 2.00601913 |
| 109 | Blue sclerae (HP:0000592) | 1.99734947 |
| 110 | Dilatation of the ascending aorta (HP:0005111) | 1.98699611 |
| 111 | Chest pain (HP:0100749) | 1.98214600 |
| 112 | Arterial tortuosity (HP:0005116) | 1.96478885 |
| 113 | Increased mean platelet volume (HP:0011877) | 1.96387288 |
| 114 | Skin ulcer (HP:0200042) | 1.94736020 |
| 115 | Loss of speech (HP:0002371) | 1.94371972 |
| 116 | Selective tooth agenesis (HP:0001592) | 1.94235719 |
| 117 | Restrictive lung disease (HP:0002091) | 1.92864460 |
| 118 | Chronic sinusitis (HP:0011109) | 1.91607442 |
| 119 | Combined immunodeficiency (HP:0005387) | 1.91279916 |
| 120 | Flat acetabular roof (HP:0003180) | 1.91218212 |
| 121 | Aneurysm (HP:0002617) | 1.91062133 |
| 122 | Ulnar bowing (HP:0003031) | 1.90934255 |
| 123 | Thyroiditis (HP:0100646) | 1.90622613 |
| 124 | Vascular tortuosity (HP:0004948) | 1.90471352 |
| 125 | Persistence of primary teeth (HP:0006335) | 1.87014772 |
| 126 | Abnormality of the Achilles tendon (HP:0005109) | 1.86992316 |
| 127 | Thin bony cortex (HP:0002753) | 1.86636051 |
| 128 | Spondylolisthesis (HP:0003302) | 1.85884126 |
| 129 | Cervical subluxation (HP:0003308) | 1.85089186 |
| 130 | Cholecystitis (HP:0001082) | 1.85070518 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.85070518 |
| 132 | Mitral valve prolapse (HP:0001634) | 1.84398298 |
| 133 | Eosinophilia (HP:0001880) | 1.82592908 |
| 134 | Gingival bleeding (HP:0000225) | 1.82146661 |
| 135 | Aortic dissection (HP:0002647) | 1.80060205 |
| 136 | Mitral regurgitation (HP:0001653) | 1.79792788 |
| 137 | Upper limb amyotrophy (HP:0009129) | 1.79684913 |
| 138 | Distal upper limb amyotrophy (HP:0007149) | 1.79684913 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.79321864 |
| 140 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79088560 |
| 141 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79088560 |
| 142 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79088560 |
| 143 | Polycythemia (HP:0001901) | 1.78175098 |
| 144 | Natal tooth (HP:0000695) | 1.78083142 |
| 145 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.76180362 |
| 146 | Reticulocytosis (HP:0001923) | 1.73467281 |
| 147 | Premature skin wrinkling (HP:0100678) | 1.73298367 |
| 148 | Hypertriglyceridemia (HP:0002155) | 1.73118497 |
| 149 | Abnormality of the thoracic spine (HP:0100711) | 1.72239346 |
| 150 | Menorrhagia (HP:0000132) | 1.72110111 |
| 151 | Elbow flexion contracture (HP:0002987) | 1.70849113 |
| 152 | Trismus (HP:0000211) | 1.68657729 |
| 153 | Bladder diverticulum (HP:0000015) | 1.67944290 |
| 154 | Advanced eruption of teeth (HP:0006288) | 1.67193880 |
| 155 | Shallow orbits (HP:0000586) | 1.67165040 |
| 156 | Dislocated radial head (HP:0003083) | 1.67122028 |
| 157 | Polygenic inheritance (HP:0010982) | 1.66753053 |
| 158 | Orthostatic hypotension (HP:0001278) | 1.65955633 |
| 159 | Hemorrhage of the eye (HP:0011885) | 1.65751455 |
| 160 | Joint laxity (HP:0001388) | 1.65616792 |
| 161 | Deep venous thrombosis (HP:0002625) | 1.63948852 |
| 162 | Long palpebral fissure (HP:0000637) | 1.63872230 |
| 163 | Nail dystrophy (HP:0008404) | 1.62838466 |
| 164 | Difficulty climbing stairs (HP:0003551) | 1.62623594 |
| 165 | J-shaped sella turcica (HP:0002680) | 1.62262541 |
| 166 | Fatigue (HP:0012378) | 1.62252770 |
| 167 | Genu recurvatum (HP:0002816) | 1.62075811 |
| 168 | Nonimmune hydrops fetalis (HP:0001790) | 1.60239439 |
| 169 | Entropion (HP:0000621) | 1.59725245 |
| 170 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.59569672 |
| 171 | Gastrointestinal dysmotility (HP:0002579) | 1.58347721 |
| 172 | Abnormality of the tricuspid valve (HP:0001702) | 1.57832556 |
| 173 | Thick nail (HP:0001805) | 1.56555416 |
| 174 | Glucose intolerance (HP:0000833) | 1.56157593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.34413641 |
| 2 | TRIB3 | 3.32310754 |
| 3 | SMG1 | 3.29369727 |
| 4 | EEF2K | 2.99850482 |
| 5 | PRPF4B | 2.93975683 |
| 6 | JAK3 | 2.71400697 |
| 7 | ERN1 | 2.54336030 |
| 8 | PKN2 | 2.54159681 |
| 9 | MAP3K10 | 2.53419780 |
| 10 | TYK2 | 2.36236645 |
| 11 | STK10 | 2.18051458 |
| 12 | ICK | 2.17443780 |
| 13 | ZAP70 | 2.13894058 |
| 14 | TXK | 2.04634173 |
| 15 | TTN | 1.97974899 |
| 16 | JAK1 | 1.91890115 |
| 17 | TBK1 | 1.87229012 |
| 18 | KIT | 1.82493729 |
| 19 | ITK | 1.76156058 |
| 20 | BLK | 1.75766172 |
| 21 | FGFR4 | 1.69917018 |
| 22 | LRRK2 | 1.67778217 |
| 23 | GRK6 | 1.64419922 |
| 24 | BTK | 1.62260938 |
| 25 | FGFR3 | 1.54707792 |
| 26 | MAP3K14 | 1.49111263 |
| 27 | TGFBR2 | 1.46653584 |
| 28 | IKBKE | 1.46640024 |
| 29 | EPHB1 | 1.39583062 |
| 30 | MAP2K3 | 1.38779670 |
| 31 | KSR2 | 1.37655942 |
| 32 | SYK | 1.37312294 |
| 33 | CDK12 | 1.35688231 |
| 34 | CSF1R | 1.33840201 |
| 35 | HCK | 1.33758760 |
| 36 | CSK | 1.32185954 |
| 37 | CAMK1D | 1.31231306 |
| 38 | LCK | 1.27292840 |
| 39 | TESK1 | 1.26344832 |
| 40 | IRAK4 | 1.24302060 |
| 41 | SIK1 | 1.24104647 |
| 42 | RPS6KA4 | 1.20184381 |
| 43 | TEC | 1.20101852 |
| 44 | EPHA2 | 1.16831715 |
| 45 | NME2 | 1.16771424 |
| 46 | TAOK3 | 1.15268378 |
| 47 | PTK6 | 1.12925449 |
| 48 | SCYL2 | 1.12122700 |
| 49 | FLT3 | 1.08717148 |
| 50 | RIPK1 | 1.08166488 |
| 51 | MAP3K1 | 1.05456634 |
| 52 | EPHA3 | 1.04825041 |
| 53 | PIM1 | 1.03909535 |
| 54 | RIPK4 | 1.02834176 |
| 55 | IKBKB | 1.01692604 |
| 56 | JAK2 | 1.01558896 |
| 57 | FES | 1.00945651 |
| 58 | SIK2 | 1.00268712 |
| 59 | TAOK2 | 1.00233835 |
| 60 | MST1R | 0.98615260 |
| 61 | PTK2 | 0.98586796 |
| 62 | PRKD2 | 0.94571059 |
| 63 | MARK3 | 0.93103206 |
| 64 | ARAF | 0.90405081 |
| 65 | TRPM7 | 0.88922260 |
| 66 | KDR | 0.87311642 |
| 67 | IRAK3 | 0.86807234 |
| 68 | PRKCH | 0.86792041 |
| 69 | NEK2 | 0.86263875 |
| 70 | CAMK1G | 0.82697297 |
| 71 | NLK | 0.82435877 |
| 72 | CDK4 | 0.81776616 |
| 73 | CDK6 | 0.80362203 |
| 74 | NTRK1 | 0.78828545 |
| 75 | MAP3K13 | 0.78651372 |
| 76 | MAP2K2 | 0.75618325 |
| 77 | LYN | 0.75466204 |
| 78 | NEK9 | 0.75121474 |
| 79 | HIPK2 | 0.74223055 |
| 80 | CHUK | 0.72950602 |
| 81 | STK38 | 0.72402894 |
| 82 | PASK | 0.71813520 |
| 83 | PIM2 | 0.70699387 |
| 84 | CDC42BPA | 0.70125774 |
| 85 | MAP3K6 | 0.69895277 |
| 86 | CLK1 | 0.69176986 |
| 87 | ALK | 0.66482173 |
| 88 | MAP3K3 | 0.66168804 |
| 89 | MOS | 0.63403812 |
| 90 | MAPKAPK3 | 0.62024112 |
| 91 | PDGFRA | 0.61615970 |
| 92 | MAP3K8 | 0.61159542 |
| 93 | PDGFRB | 0.60506664 |
| 94 | TESK2 | 0.60315809 |
| 95 | LMTK2 | 0.60247280 |
| 96 | RPS6KB2 | 0.60195420 |
| 97 | MARK2 | 0.59224582 |
| 98 | PDPK1 | 0.57760962 |
| 99 | CDK9 | 0.57056880 |
| 100 | CDK7 | 0.56616295 |
| 101 | MAP3K2 | 0.55496384 |
| 102 | TGFBR1 | 0.55223698 |
| 103 | BMX | 0.54401090 |
| 104 | STK4 | 0.54278619 |
| 105 | PAK4 | 0.53944960 |
| 106 | TNK2 | 0.52378042 |
| 107 | RAF1 | 0.51819828 |
| 108 | DMPK | 0.50812302 |
| 109 | MTOR | 0.50532355 |
| 110 | EIF2AK1 | 0.49386314 |
| 111 | MELK | 0.46789838 |
| 112 | RET | 0.46321965 |
| 113 | SIK3 | 0.46173627 |
| 114 | MAP3K11 | 0.45028457 |
| 115 | RPS6KA6 | 0.45022609 |
| 116 | ILK | 0.44899094 |
| 117 | PRKCQ | 0.44023261 |
| 118 | TAOK1 | 0.42902525 |
| 119 | MAPKAPK2 | 0.42754050 |
| 120 | PRKG2 | 0.41856910 |
| 121 | PDK1 | 0.40924995 |
| 122 | MAP3K7 | 0.40172499 |
| 123 | MAP3K9 | 0.40038909 |
| 124 | MET | 0.39878152 |
| 125 | EGFR | 0.39246609 |
| 126 | RPS6KL1 | 0.38412770 |
| 127 | RPS6KC1 | 0.38412770 |
| 128 | RPS6KA2 | 0.38284757 |
| 129 | ABL1 | 0.37666765 |
| 130 | PAK2 | 0.37281863 |
| 131 | MAPK11 | 0.35497494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.87103308 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54093317 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.38479944 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25727258 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21599025 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15895842 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.14203666 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05514993 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02792667 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.86714354 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78515712 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.76630947 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71672566 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70376108 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69987641 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69111608 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65565262 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.61292392 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57959959 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55767326 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55395258 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50978652 |
| 23 | Apoptosis_Homo sapiens_hsa04210 | 1.49548128 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49398868 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48809072 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.44922625 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44402968 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.43335088 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.42410599 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42382060 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.42380254 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.41491111 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.41474359 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.40663181 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.38234091 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36014376 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34612816 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.33689718 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33264335 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32152827 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.31756830 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.31229515 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30254931 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29639661 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.28386148 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26220468 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26056381 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.24858251 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21085353 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12326259 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10644483 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07583581 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06867264 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05471052 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 1.04050307 |
| 56 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.03779906 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00353547 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99469073 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96776568 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95406030 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94482505 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93685468 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.93531850 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93525075 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93489921 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93025066 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.91712726 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.89416173 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89259590 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.88225391 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86584021 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84809038 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81899117 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81638513 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.81481980 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81324030 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80784693 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80084364 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79846822 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79140515 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78713176 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78334735 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76040456 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75738559 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.75408752 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74465786 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73236039 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72188197 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.70015557 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.69403062 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65956641 |
| 92 | DNA replication_Homo sapiens_hsa03030 | 0.65382148 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64091874 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.63287796 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62738865 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60849939 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60673376 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60353251 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58932949 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58644820 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58584099 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57984143 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57027227 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56075815 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55669917 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55660379 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.55419584 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54908337 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54541693 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53795898 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53739178 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.52901216 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51432203 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50849020 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50172320 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49862330 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49301859 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47556306 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47425015 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.46771113 |
| 121 | Adherens junction_Homo sapiens_hsa04520 | 0.46332254 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42697516 |
| 123 | Base excision repair_Homo sapiens_hsa03410 | 0.40792480 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40544391 |
| 125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39260562 |

